TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PRTA

Prothena Corporation plc

Healthcare · Biotechnology

8.60$ +1.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Prothena Corporation plc (PRTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -164 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PRTA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.7 -62 -117 -131 -28 -53 -80 93 -109 -134 -150 -164
0.7 0.8 2.4 3.1 3.2 6.8 1.5 1.1 0.7 0.9 0.9 0.9
5.6 10 25 27 27 24 22 25 31 41 46 38
4.3 5.9 21 22 -1.0 -1.2 -1.7 4.6 20
1.4 11 19 -7.2 94 -4.4 3.5 -10 -19 -21 -68 -4.2
0.5 1.4 17 3.6 1.8 0.6 0.2 0.6 0.5 2.8 0.3 0.1
-0.5 -1.4 -17 -3.5 -1.7 -0.5 -0.2 -0.6 -0.5 -2.8 -0.3 -0.1
0.0 0.0 0.0 0.0
118 137 139 168 44 0.2 0.2 94 -0.4 -0.1
-0.2 -0.2 -0.2 -2.8 -4.4
118 141 154 165 40 0.2 0.2 190 241 45 1.6 -0.1
117 77 20 31 10 -53 -80 282 132 -92 -149 -164
-1.2 -64 -134 -135 -30 -54 -81 92 -109 -137 -150 -164

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?